Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 4 - Jul 9
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Die Sache mit dem WaldNeue Perspektiven und Konzepte fr unser kosystem EAN: 9783440175293 Farbverschnitt: Generell werden die Bcher ohne Farbverschnitt geliefert, auch wenn die Abbildungen einen Farbverschnitt zeigen. Erscheinungsjahr: 17. 02. 2023 Produktform: Leinen, Gebunden Autoren: Herzog, Sven Seitenzahl Blattzahl: 352 Abbildungen: 100 farbige Fotos Keyword: Forst; Forstwirtschaft; Diskussion; Waldentwicklung; Frster; Klima; Artenschutz; Bume; Baum; Sachbuch;
Neue Perspektiven und Konzepte für unser Ökosystem
| EAN: | 9783440175293 |
| Farbverschnitt: | Generell werden die Bücher ohne Farbverschnitt geliefert, auch wenn die Abbildungen einen Farbverschnitt zeigen. |
| Erscheinungsjahr: | 17.02.2023 |
| Produktform: | Leinen, Gebunden |
| Autoren: | Herzog, Sven |
| Seitenzahl/Blattzahl: | 352 |
| Abbildungen: | 100 farbige Fotos |
| Keyword: | Forst; Forstwirtschaft; Diskussion; Waldentwicklung; Förster; Klima; Artenschutz; Bäume; Baum; Sachbuch; Gesellschaft Wald; Auswirkungen |
| Fachschema: | Forst~Wald / Forst~Wald |
| Thema: | Verstehen, Orientieren |
| Fachkategorie: | Bäume, Wildblumen und Pflanzen: Sachbuch |
| Text Sprache: | ger |
| Verlag: | Franckh-Kosmos, Kosmos |
| Länge: | 221 mm |
| Breite: | 145 mm |
| Höhe: | 30 mm |
| Gewicht: | 565 gr |
| Genre: | Sachbuch/Ratgeber |
| Herkunftsland: | DEUTSCHLAND (DE) |
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.6 ★★★★★
Based on 1120 reviews
Sort
Product Reviews
★★★★★ 5
Latex allergy stopped me from taking bromelain
I was excited to find a natural solution to inflammation and sinus issues. However, after taking this for less than a week, I had a nosebleed that wouldn't stop. After a deep dive on Google, I found out that if you are allergic to latex, you shouldn't take bromelain. Latex Cross-Reactivity: Bromelain is derived from pineapple. People with a latex allergy are at higher risk of an allergic reaction to bromelain. This allergy can manifest as sneezing, itchy throat, or inflammation in the sinuses, which can trigger nosebleeds. I was taking this to get rid of the inflammation in my sinuses, not add to it. I also had tingling in my fingers, which a deep dive on Google said could happen if I am sensitive to quercetin. Quercetin Side Effects: While generally safe, high-dose or sensitive use of quercetin can cause "tingling in the extremities" (numbness/tingling in hands/feet). Thus is neither a high dose of eother of these, nor was it used long-term, so I guess I am sensitive to them both. Beware if you are sensitive to medications and/or have a latex allergy. I can't say if these pills made a positive impact on me, because I only found negative effects, but that is due to my body being so quirky.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 29, 2026
★★★★★ 5
Good
Love this product, take it daily
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 30, 2026
★★★★★ 5
Worth the money
It the first thing I drink in the morning
Taste is good, easy to use, keeps my body happy.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 6, 2026
★★★★★ 5
Metamucil with a fiz!
Great product. Does what it’s supposed to do.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 9, 2026
★★★★★ 5
Competitive pricing
Works as advertised
Name brand item
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 5, 2026